Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
Hida, Akira I., Sagara, Yasuaki, Yotsumoto, Daisuke, Kanemitsu, Shuichi, Kawano, Junko, Baba, Shinichi, Rai, Yoshiaki, Oshiro, Yumi, Aogi, Kenjiro, Sagara, Yoshiaki, Ohi, YasuyoVolume:
158
Langue:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-016-3848-2
Date:
July, 2016
Fichier:
PDF, 1.48 MB
english, 2016